Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
03 Juin 2024 - 5:00PM
Business Wire
Agilent Technologies Inc., (NYSE: A) is introducing two new
products at the 72nd ASMS Conference on Mass Spectrometry and
Allied Topics. The Agilent 7010D Triple Quadrupole GC/MS System
which targets the food and environmental markets, offers precision
and sensitivity in gas chromatography-mass spectrometry.
Additionally, the Agilent ExD Cell for use with the 6545XT
AdvanceBio LC/Q-TOF system, serves the biopharma market and life
science research. These instruments exemplify Agilent’s unwavering
commitment to advancing scientific discovery through innovative
instrumentation, significantly shaping the landscape of mass
spectrometry.
The Agilent 7010D Triple Quadrupole GC/MS System (7010D GC/TQ)
features the new HES 2.0 ion source, providing attogram-level
sensitivity, unmatched robustness, and industry-leading uptime.
Built-in intelligence, including SWARM autotune and Early
Maintenance Feedback (EMF), streamlines analytical workflows and
reduces unplanned instrument downtime, making it a reliable partner
in navigating evolving regulatory requirements.
The 7010D GC/TQ also includes the My Green Lab Accountability,
Consistency, and Transparency (ACT) Label, reflecting
environmentally conscious manufacturing practices. Additionally,
the MassHunter Acquisition 13.0 software enhances user experience
with a refreshed interface and compliance tools, enabling users to
take control of data integrity and adhere to compliance guidelines
such as FDA 21 CFR Part 11, EU Annex 11, and GAMP5.
The Agilent ExD Cell available for the 6545XT AdvanceBio
LC/Q-TOF enhances peptide and protein characterization capabilities
by adding electron capture dissociation (ECD). With the trend
towards increasingly complex biotherapeutics this meets the need
for more thorough structural characterization.
The field installable ExD cell addon for the 6545XT is designed
for researchers in the ‘discovery phase’ who are faced with diverse
analytical challenges. ECD is particularly appropriate for the
study of large proteins, fragile modifications, and isomeric
residues – analytes which can be difficult to unambiguously
characterize with traditional collision induced dissociation (CID)
methods alone.
Coupled with the inherent capabilities of the 6545XT for intact
protein analyses, the ExD cell is also suited for performing top to
middle down characterization of large and highly charged proteins
(such as antibodies) and smaller subunits (such as peptides), and
the rich spectra produced can be interpreted with confidence using
the ExDViewer.
“Intelligence capabilities are seamlessly integrated into
instruments like the 7010D GC/TQ, recognizing the fiercely
competitive landscape that is constantly evolving. Additionally,
the Agilent ExD cell, in conjunction with the 6545XT AdvanceBio
LC/Q-TOF, empowers scientists to meticulously scrutinize and more
effectively characterize peptides—critical components in modern
research and therapeutics,” stated Ken Suzuki, vice president and
general manager of Agilent’s Mass Spectrometry Division.
“These cutting-edge products exemplify customer-driven
innovation and excellence. By listening to our customers, we gain
valuable insights into their challenges. We then channel this
understanding into consistent innovation, resulting in outstanding
products that precisely meet their needs,” added Suzuki.
Agilent is a leading solution provider of proven, robust, and
reliable mass spectrometry technologies to a range of segments and
a wide array of applications in the bio/pharma, life science
research, food, and environmental markets. These new technological
capabilities enable Agilent’s customers to increase data quality
and interpretation while reducing the time and human attention
required—more easily adapting to ever-changing market needs.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in
analytical and clinical laboratory technologies, delivering
insights and innovation that help our customers bring great science
to life. Agilent’s full range of solutions includes instruments,
software, services, and expertise that provide trusted answers to
our customers' most challenging questions. The company generated
revenue of $6.83 billion in fiscal 2023 and employs approximately
18,000 people worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest
Agilent news, please subscribe to the Agilent Newsroom. Follow
Agilent on LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240603038344/en/
Naomi Goumillout Agilent Technologies, Inc. +1.978.314.1862
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Agilent Technologies (NYSE:A)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024